Valuations in the Market

Cannabis company valuations are volatile. Where they are today is very different from what we saw just a few months ago and likely will be very different a few months from now. This session will hit on these points as well as how you should read valuations in the market. You’ll get insights on: How […]

Read More… from Valuations in the Market

Assessing US Markets

Until the United States legalizes marijuana at the federal level, the industry faces a patchwork of individual markets in states that have already taken that step. For those looking to invest now, it’s critical to keep in mind that no two markets are alike. You’ll get insights on: The clear – and numerous – differences […]

Read More… from Assessing US Markets

International Opportunities

Cannabis legalization has moved forward in many countries around the globe, but each market has approached it in very different ways. Where are opportunities for investors looking to international markets? You’ll get insights on: Key players taking the lead in markets outside the United States and Canada. Export opportunities from Latin America: What’s a realistic […]

Read More… from International Opportunities

Processing & Manufacturing: Clearing the Confusion

The cannabis industry is flush with processors and manufacturers that aren’t able to differentiate themselves clearly for high-level investors. Those investors looking capitalize on this arena should consider leading innovators that are keeping abreast of how customers are consuming the product. You’ll gain insights on: Why consumption trends matter to long-term capital gains. Innovation: How […]

Read More… from Processing & Manufacturing: Clearing the Confusion

Direct Investment

Because the marijuana industry lacks a federally legal status in the United States, many of the key players are still privately owned – and their doors are open for investors. The panelists will discuss their own experiences as direct investors and what they learned. You’ll get insights on: Key risks and opportunities of investing in […]

Read More… from Direct Investment

Investing in Ancillary Companies

The opportunities for many investors may be limited by marijuana’s federally illegal status – either by firm compliance rules or just a hesitation to embrace that level of risk. But it takes more than just the plant to establish a successful industry, which sets the stage for many ancillary opportunities. You’ll gain insights on: • […]

Read More… from Investing in Ancillary Companies

Hemp: Hype vs. Reality

With the passage of the Farm Bill in 2018, hemp is technically legal in the United States now, but the industry is still operating under a patchwork of regulations for the time being. Learn how to look through the confusion to see the companies ripe for investing. You’ll gain insights on: Where the industry sits […]

Read More… from Hemp: Hype vs. Reality

Ready to Invest?™ Presented in Collaboration with the Arcview Group

Ready to Invest?TM with The Arcview Group: The Arcview Group’s Ready to Invest?TM session, is a fun, interactive “Shark Tank”-style pitch presentation with our most exciting, curated, up-and-coming companies. Companies present on stage to the audience and a select group of investor experts who dig deeper. The Arcview Group’s goal is to present real and compelling […]

Read More… from Ready to Invest?™ Presented in Collaboration with the Arcview Group

Cowen Master Class

The Cowen Master Class: Cowen’s unique Master Class* is an invitation-only seminar for sophisticated institutional and family office investors, led by acclaimed research analyst and Cowen Managing Director, Vivien Azer. Leveraging her years of experience as a highly ranked analyst in the global beverages, tobacco and cannabis sectors, Vivien will bring together CEOs at the […]

Read More… from Cowen Master Class